Aurora Diagnostics Acquires Pacific Pathology Associates in Oregon

Acquisition establishes Aurora’s first presence in Pacific Northwest

SALEM, Ore. – Aurora Diagnostics announced today that it has acquired
Pacific Pathology Associates, a hospital-based practice providing
professional and technical pathology services to five hospitals and more
than 225 physicians’ offices in 17 cities in the Willamette Valley area.

The acquisition establishes Aurora Diagnostics in the Pacific Northwest
region. Notably, this is the seventh acquisition that Aurora Diagnostics has successfully
completed since 2013 under its current management team. With this acquisition, Aurora
Diagnostics now operates 25 labs.

Pacific Pathology Associates operates one technical processing lab near Salem Hospital.
The practice provides extensive pathology services, including surgical pathology,
cytopathology, hematopathology, immunohistochemistry, flow cytometry, fine needle
aspiration, and bone marrow aspiration and biopsy.

“We are pleased to welcome the successful team at Pacific Pathology Associates
to Aurora Diagnostics,” said Daniel D. Crowley, President, Chairman and CEO of
Aurora Diagnostics. “As the only pathology group of its kind in the region,
Pacific Pathology Associates is relied upon to provide exceptional
pathology services. We will help the group reach out to new clients and
maintain its reputation for premier inpatient and outpatient pathology services.”

“Joining the Aurora Diagnostics team provides Pacific Pathology Associates with
additional resources and new capabilities to serve our community,” said Clark McDonald,
M.D., the Board-certified pathologist who led the ownership group of Pacific Pathology
Associates and who will continue to lead the local lab after the transaction. “Aurora has
a reputation for affiliating with high quality labs that maintain strong local
relationships. This, together with our excellent team and unique role in serving this
community, will help make this a successful relationship for our clients.”

This acquisition is Aurora’s fifth in the hospital laboratory sector since 2013. Serving 85 hospitals
throughout the U.S., the Company is a leader in outsourced hospital lab management services.

Additionally, its Aurora Research Institute subsidiary is a leader in helping hospitals and
independent labs to ethically provide tissue and blood samples to researchers on the cutting
edge of research for effective cancer treatments.

“This acquisition builds on our ability to meet the needs of hospitals in the rapidly changing
healthcare environment,” said Mr. Crowley.

Terms of the transaction were not disclosed.

About Aurora Diagnostics
Aurora Diagnostics is the leading independent specialized laboratory company focused on
anatomic pathology at 25 locations in the United States. Employing over 150 licensed physicians,
Aurora Diagnostics provides high-quality diagnostics and testing information for the patients
of its primary referral sources—dermatologists, OB/GYN professionals, gastroenterologists,
urologists, general surgeons, oncologists, and for 85 community hospitals. For additional
information regarding Aurora Diagnostics and the services it provides, please visit the
company website at www.auroradx.com.